1st Quarter - Report
W STRATEGIES, LLC for ASTRAZENECA PHARMACEUTICALS LP
Firm
Income
$30,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
H.R. 9: Innovation Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Health Issues HCR
Legislative efforts to help accelerate the discovery, development and delivery of promising new treatments to patients (21st Century Cures).
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Medicare/Medicaid MMM
Education on the importance of maintaining the competitive elements of the Part D prescription drug program and to oppose efforts to impose mandatory government rebates in that program and proposed changes to cost sharing for low income seniors. H.R. 2: Medicare Access and CHIP Reauthorization Act of 2015.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.